Osaic Holdings’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $292K | Buy |
3,052
+1,693
| +125% | +$162K | ﹤0.01% | 3278 |
|
|
2025
Q1 | $158K | Sell |
1,359
-1,151
| -46% | -$134K | ﹤0.01% | 3827 |
|
|
2024
Q4 | $141K | Buy |
2,510
+875
| +54% | +$49.1K | ﹤0.01% | 3905 |
|
|
2024
Q3 | $147K | Sell |
1,635
-887
| -35% | -$79.7K | ﹤0.01% | 3904 |
|
|
2024
Q2 | $203K | Sell |
2,522
-284
| -10% | -$22.9K | ﹤0.01% | 3542 |
|
|
2024
Q1 | $224K | Sell |
2,806
-1,683
| -37% | -$134K | ﹤0.01% | 3587 |
|
|
2023
Q4 | $357K | Sell |
4,489
-700
| -13% | -$55.7K | ﹤0.01% | 3447 |
|
|
2023
Q3 | $363K | Sell |
5,189
-713
| -12% | -$49.8K | ﹤0.01% | 3521 |
|
|
2023
Q2 | $424K | Sell |
5,902
-1,002
| -15% | -$72K | ﹤0.01% | 3284 |
|
|
2023
Q1 | $426K | Buy |
6,904
+1,808
| +35% | +$112K | ﹤0.01% | 3238 |
|
|
2022
Q4 | $393K | Sell |
5,096
-1,020
| -17% | -$78.6K | ﹤0.01% | 3240 |
|
|
2022
Q3 | $272K | Buy |
6,116
+995
| +19% | +$44.3K | ﹤0.01% | 3465 |
|
|
2022
Q2 | $197K | Sell |
5,121
-332
| -6% | -$12.8K | ﹤0.01% | 3812 |
|
|
2022
Q1 | $237K | Sell |
5,453
-277
| -5% | -$12K | ﹤0.01% | 3884 |
|
|
2021
Q4 | $217K | Sell |
5,730
-171
| -3% | -$6.48K | ﹤0.01% | 3861 |
|
|
2021
Q3 | $195K | Buy |
5,901
+1,754
| +42% | +$58K | ﹤0.01% | 3925 |
|
|
2021
Q2 | $279K | Buy |
4,147
+819
| +25% | +$55.1K | ﹤0.01% | 3582 |
|
|
2021
Q1 | $189K | Buy |
3,328
+1,585
| +91% | +$90K | ﹤0.01% | 3780 |
|
|
2020
Q4 | $142K | Sell |
1,743
-126
| -7% | -$10.3K | ﹤0.01% | 3766 |
|
|
2020
Q3 | $133K | Sell |
1,869
-800
| -30% | -$56.9K | ﹤0.01% | 3590 |
|
|
2020
Q2 | $219K | Sell |
2,669
-2,090
| -44% | -$171K | ﹤0.01% | 3052 |
|
|
2020
Q1 | $280K | Buy |
+4,759
| New | +$280K | ﹤0.01% | 2581 |
|